GE HealthCare said it has received FDA Premarket Authorization for Pristina Recon DL, a deep-learning–powered 3D mammography reconstruction technology the company says improves image sharpness and ...

GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep ...

More than 80 percent of all health system visits include an imaging exam, i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare ...

New 3D imaging capabilities of Sonic DL are designed to enable up to 86% i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL ...

Annual Meeting, GE HealthCare showcased more than 40 new innovations, including AI-powered imaging platforms, next-generation CT and MRI technologies, and advancements in cloud-based radiology ...

GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with ...

NVIDIA technology is now integrated into several of GE HealthCare’s new imaging solutions, including Photonova Spectra1, SIGNA Sprint with Freelium2, SIGNA Bolt3, Vivid Pioneer, and Pristina Recon DL.

GE HealthCare’s Pristina Recon DL tool has received pre-market authorisation (PMA) from the US Food and Drug Administration (FDA).

GE HealthCare (Nasdaq: GEHC) announced that it submitted its next-generation Signa Bolt MRI technology to the FDA for 510(k) ...